Conference Coverage
Conference Coverage
Autoimmune disease linked to better late-stage breast cancer survival
Retrospective data hint at antitumor activity, but other explanations are possible
Conference Coverage
Breast cancer deaths take a big dip because of new medicines
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.
Conference Coverage
Hormonal contraceptives protective against suicide?
The main message is the “current use of hormonal contraceptives is not associated with an increased risk of attempted suicide in our population...
Conference Coverage
Surgeons may underestimate recovery from incontinence operation
The researchers found that just over 40% of women reported returning to work and other normal activities within 2 weeks of having undergone...
Conference Coverage
Male contraceptive pill appears feasible in very early trials
By lowering testosterone levels without untoward hypogonadism, early data show that once-daily contraceptive pills for men could be feasible.
Conference Coverage
MS and family planning: Bring it up at every office visit
It’s crucial to counsel women of child-bearing age about options and facts regarding pregnancy, neurologist says.
Conference Coverage
Biologics, Women, and Pregnancy: What’s Known?
As more studies emerge each year, recommendations will become stronger for considering treatment by certain biological drugs, taking into account...
Latest News
Women are not being warned that anesthetic may reduce birth pill efficacy
“Use of sugammadex is expected to rise as it becomes cheaper in the future, and ensuring that women receiving this medicine are aware it may...
Conference Coverage
Pseudocirrhosis in breast cancer may signal liver metastases
A better understanding of this common comorbidity could lead to better management and treatment.
Conference Coverage
Excess weight may ward off infection in breast cancer treatment
The study demonstrated significantly less frequent and less severe neutropenia in overweight and obese patients.
Conference Coverage
Women with HER2+ metastatic breast cancer are living longer
Overall survival improved 5.6% each year among over 5,000 patients in the study.